Part:BBa K1694005 - parts.igem.org
Addgene: pVITRO1-Trastuzumab-IgG1/κ
Trastuzumab: Uses, Interactions, Mechanism of Action | DrugBank Online
EP2540745A9 - Fully humanized anti-her2 antibody, preparation method and use thereof - Google Patents
Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation Scheme | Journal of Proteome Research
Sequence alignment of the V H and V L domains of trastuzumab. A... | Download Scientific Diagram
e The amino acid sequences of one side of trastuzumab IgG and the... | Download Scientific Diagram
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo: Molecular Therapy
In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin Akbarzadeh-Sharbaf S, Yakhchali B, Minuchehr Z, Shokrgozar MA, Zeinali S - Adv Biomed Res
Structure of trastuzumab (Herceptin) Fab in complex with extracellular... | Download Scientific Diagram
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer | SpringerLink
The TANGO and PAGE profiles for trastuzumab (Herceptin) mAb. (A) Light... | Download Scientific Diagram
Conformational characterization of a novel anti-HER2 candidate antibody | PLOS ONE
Enhertu (Trastuzumab Deruxtecan) Treatment of HER2+ Breast Cancer - CancerConnect
Addgene: pVITRO1-Trastuzumab-IgG1/κ
Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin® with a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology | SpringerLink
111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer | Journal of Nuclear Medicine
CDR regions of Trastuzumab F(ab') 2 Light Chain and Heavy Chain Based... | Download Scientific Diagram
Targeted Intracellular Delivery of Trastuzumab Using Designer Phage Lambda Nanoparticles Alters Cellular Programs in Human Breast Cancer Cells | ACS Nano
Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators | PLOS ONE
EP2540745A9 - Fully humanized anti-her2 antibody, preparation method and use thereof - Google Patents
Comparison of two-dimensional gel electrophoresis patterns and MALDI-TOF MS analysis of therapeutic recombinant monoclonal antibodies trastuzumab and rituximab - ScienceDirect
Frontiers | A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo
Multiple alignment of the trastuzumab amino acid sequence by ClustalW... | Download Scientific Diagram
